Уноси

• Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225 (2018-04)

  I. Andreadou, P. Adamovski, M. Bartekova, C. Beauloye, L. Bertrand, D. Biedermann, V. Borutaite, H. Erik Botker, M. Dambrova, S. Chlopicki, Y. Devaux, S. Davidson, F. Di Lisa, D. Djuric, D. Erlinge, I. Falcao-Pires, E. Galatou, D. Garcia-Dorado, A. Garcia-Sosa, H. Girao, M. Gyongyosi, Z. Giricz, D. Healy, G. Heusch, V. Jakovljevic, J. Jovanic, F. Kolar, B. Kwak, P. Leszek, E. Liepnish, S. Longnus, J. Marinovic, D. Muntean, L. Nežić, M. Ovize, P. Paglliaro, C. Pedrosa da Costa Gomes, J. Pernow, A. Persidis, S. Pischke, B. Podesser, F. Prunier, T. Ravingerova, M. Ruiz-Meana, R. Schulz, A. Scridon, K. Slagsvold, J. Lonborg, B. Turan, N. van Royen, M. Vendelin, S. Walsh, D. Yellon, N. Zidar, C. Zuurbier, P. Ferdinandy, D. Hausenloy, Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225, Conditioning medicine, Vol. 1, No. 3, pp. 116 - 123, Apr, 2018

• IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action (2021-09)

  S. Lecour, I. Andreadou, H. Botker, S. Davidson, G. Heusch, M. Ruiz-Meana, R. Schulz, C. Zuurbier, P. Ferdinandy, D. Hausenloy, E. COST ACTION CA16225, L. Nežić, IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action, BASIC RESEARCH IN CARDIOLOGY, Vol. 116, pp. 1 - 8, Sep, 2021